We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+7.87%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$9.04B
AUM Growth
+$2.19B
Cap. Flow
+$1.88B
Cap. Flow %
20.78%
Top 10 Hldgs %
34.88%
Holding
3,092
New
1,032
Increased
581
Reduced
587
Closed
820

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$435M
2
AMZN icon
Amazon
AMZN
+$334M
3
MRNA icon
Moderna
MRNA
+$53.9M
4
LIN icon
Linde
LIN
+$44.2M
5
DTE icon
DTE Energy
DTE
+$43.5M

Sector Composition

Rank Sector Weight
1 Technology 15.37%
2 Consumer Discretionary 10.36%
3 Financials 7.14%
4 Industrials 6.8%
5 Healthcare 6.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BABA icon
1
PUT
Alibaba
BABA
$286B
$691M 7.65%
3,049,100
MSFT icon
2
Microsoft
MSFT
$3.59T
$481M 5.32%
1,776,592
+1,710,249
+2,578% +$435M
MSFT icon
3
PUT
Microsoft
MSFT
$3.59T
$466M 5.15%
1,720,000
+1,710,000
+17,100% +$435M
BABA icon
4
CALL
Alibaba
BABA
$286B
$429M 4.75%
1,893,000
AMZN icon
5
Amazon
AMZN
$2.79T
$366M 4.05%
2,126,860
+2,011,860
+1,749% +$334M
AMZN icon
6
PUT
Amazon
AMZN
$2.79T
$344M 3.81%
+2,000,000
New +$332M
SPY icon
7
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$809B
$153M 1.69%
357,800
+175,900
+97% +$73.4M
MRNA icon
8
Moderna
MRNA
$57.9B
$79.1M 0.87%
336,506
+301,520
+862% +$53.9M
ETR icon
9
Entergy
ETR
$48.8B
$75.2M 0.83%
1,507,568
-39,702
-3% -$2.09M
CMS icon
10
CMS Energy
CMS
$21.4B
$69.1M 0.76%
1,169,934
+418,963
+56% +$26.1M
LYFT icon
11
PUT
Lyft
LYFT
$6.61B
$49.5M 0.55%
818,100
SO icon
12
Southern Company
SO
$102B
$47.3M 0.52%
782,265
+535,113
+217% +$34.2M
PYPL icon
13
PayPal
PYPL
$52.7B
$45.8M 0.51%
157,181
+80,817
+106% +$21.3M
AEP icon
14
American Electric Power
AEP
$65.8B
$43.9M 0.49%
518,861
-40,843
-7% -$3.52M
LIN icon
15
Linde
LIN
$225B
$43.9M 0.49%
+151,692
New +$44.2M
DTE icon
16
DTE Energy
DTE
$28.1B
$41.1M 0.45%
+372,287
New +$43.5M
NI icon
17
NiSource
NI
$19.5B
$41M 0.45%
1,673,876
+100,970
+6% +$2.57M
T icon
18
AT&T
T
$173B
$40.7M 0.45%
+1,874,155
New +$42.6M
CNP icon
19
CenterPoint Energy
CNP
$25.5B
$36.1M 0.4%
1,470,400
+78,190
+6% +$1.92M
CRM icon
20
Salesforce
CRM
$171B
$33.9M 0.38%
138,823
+63,317
+84% +$14.6M
PRAH
21
DELISTED
PRA Health Sciences, Inc.
PRAH
$32.2M 0.36%
195,151
+193,722
+13,556% +$32.3M
VMW
22
PUT
DELISTED
VMware, Inc
VMW
$32M 0.35%
+200,000
New +$32M
NUAN
23
DELISTED
Nuance Communications, Inc.
NUAN
$31.1M 0.34%
570,771
+419,098
+276% +$22.1M
LQD icon
24
PUT
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$33.1B
$29.3M 0.32%
+217,900
New +$28.7M
BBWI icon
25
CALL
Bath & Body Works
BBWI
$3.92B
$28.8M 0.32%
494,800
+309,250
+167% +$16.7M

Similar funds

Michael Gelband's Q2 2021 Portfolio in Review

As of Q2 2021, Michael Gelband held 3,092 positions worth $9.04B, up 32% from $6.86B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Michael Gelband deployed $1.88B of net new capital in Q2 2021, opening 1,032 new positions and adding to 581 existing holdings. Its largest new stake was Linde: 151,692 shares worth $43.9M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 1000 Value ETF, an estimated $63.6M trimmed.

  • Michael Gelband's largest Q2 2021 buy was Linde: 151,692 shares worth $43.9M.
  • Michael Gelband added most to Microsoft in Q2 2021, an estimated $435M increase.
  • Michael Gelband's biggest Q2 2021 reduction was iShares Russell 1000 Value ETF, cutting an estimated $63.6M.
  • Michael Gelband fully exited Charles River Laboratories in Q2 2021, selling an estimated $27.9M.
  • Michael Gelband's ten largest holdings make up 35% of its $9.04B portfolio in Q2 2021.
  • Michael Gelband opened 1,032 new positions and closed 820 in Q2 2021.
  • Michael Gelband's portfolio value rose 32% quarter-over-quarter to $9.04B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.